About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Ikzf1
IKAROS family zinc finger 1
MGI:1342540
128 phenotypes from 11 alleles in 15 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Cd79atm1(cre)Reth/Cd79a+
Ikzf1tm3.1Mbu/Ikzf1tm3.1Mbu
involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL 		abnormal B cell differentiation J:209928
abnormal B cell number J:209928
decreased pre-B cell number J:209928
increased pro-B cell number J:209928
normal neoplasm J:209928
Ikzf1m1Btlr/Ikzf1m1Btlr
C57BL/6J-Ikzf1m1Btlr 		abnormal natural killer cell mediated cytotoxicity J:265249
decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number J:265249
decreased CD8-positive, naive alpha-beta T cell number J:265249
decreased heart rate J:265249
enhanced humoral immune response J:265249
increased B-1 B cell number J:265249
increased CD4-positive, alpha-beta T cell number J:265249
increased CD8-positive, alpha-beta T cell number J:265249
increased central memory CD4-positive, alpha-beta T cell number J:265249
increased central memory CD8 positive, alpha-beta T cell number J:265249
increased effector memory CD4-positive, alpha-beta T cell number J:265249
increased IgG level J:265249
increased response to antigen J:265249
increased single-positive T cell number J:265249
increased T cell number J:265249
Ikzf1m2Btlr/Ikzf1m2Btlr
C57BL/6J-Ikzf1m2Btlr 		decreased B cell number J:265250
decreased CD4-positive, alpha-beta T cell number J:265250
decreased CD8-positive, naive alpha-beta T cell number J:265250
decreased heart rate J:265250
decreased single-positive T cell number J:265250
decreased T cell number J:265250
increased CD8-positive, alpha-beta T cell number J:265250
increased central memory CD4-positive, alpha-beta T cell number J:265250
increased central memory CD8 positive, alpha-beta T cell number J:265250
increased effector memory CD4-positive, alpha-beta T cell number J:265250
increased effector memory CD8-positive, alpha-beta T cell number J:265250
increased single-positive T cell number J:265250
Ikzf1m3Btlr/Ikzf1m3Btlr
C57BL/6J-Ikzf1m3Btlr 		decreased CD4-positive, alpha-beta T cell number J:265251
increased B-1 B cell number J:265251
increased CD8-positive, alpha-beta T cell number J:265251
increased single-positive T cell number J:265251
increased T cell number J:265251
Ikzf1plstc/Ikzf1+
C57BL/6JSfdAnu-Ikzf1plstc 		abnormal B cell differentiation J:84569
abnormal lymphopoiesis J:84569
abnormal T cell differentiation J:84569
decreased double-negative T cell number J:84569
decreased double-positive T cell number J:84569
decreased mature B cell number J:84569
decreased pre-B cell number J:84569
decreased thymocyte number J:84569
increased leukemia incidence J:84569
increased pro-B cell number J:84569
increased T cell derived lymphoma incidence J:84569
liver hypoplasia J:84569
myeloid hyperplasia J:84569
premature death J:84569
Ikzf1plstc/Ikzf1plstc
C57BL/6JSfdAnu-Ikzf1plstc 		abnormal erythroblast morphology J:84569
abnormal granulocyte differentiation J:84569
abnormal lymphopoiesis J:84569
abnormal macrophage differentiation J:84569
abnormal myelopoiesis J:84569
absent pro-B cells J:84569
absent T cells J:84569
anemia J:84569
arrested B cell differentiation J:84569
decreased erythrocyte cell number J:84569
decreased erythroid progenitor cell number J:84569
decreased fetal derived definitive erythrocyte cell number J:84569
decreased granulocyte number J:84569
decreased hematocrit J:84569
decreased hemoglobin content J:84569
increased macrophage cell number J:84569
lethality throughout fetal growth and development, complete penetrance J:84569
liver hypoplasia J:84569
pallor J:84569
reticulocytopenia J:84569
thymus hypoplasia J:84569
Ikzf1plstc/Ikzf1tm2Kge
involves: 129S4/SvJae * C57BL/6 * C57BL/6JSfdAnu 		abnormal erythropoiesis J:84569
anemia J:84569
Ikzf1tm1.1Smale/Ikzf1tm1.1Smale
B6.Cg-Ikzf1tm1.1Smale 		decreased B cell number J:208211
decreased B-1a cell number J:208211
decreased B-1b cell number J:208211
decreased DN1 thymic pro-T cell number J:208211
decreased immature B cell number J:208211
decreased mature B cell number J:208211
decreased pre-B cell number J:208211
normal immune system phenotype J:208211
normal neoplasm J:208211
thymus hypoplasia J:208211
Ikzf1tm1.1Smale/Ikzf1tm2Kge
involves: 129S4/SvJae * C57BL/6 		lethality, complete penetrance J:208211
Ikzf1tm1Kast/Ikzf1tm1Kast
involves: 129S2/SvPas 		abnormal B cell activation J:82813
abnormal B cell differentiation J:82813
decreased B cell number J:82813
decreased B cell proliferation J:82813
decreased B-1a cell number J:82813
decreased B-1b cell number J:82813
decreased IgG3 level J:82813
decreased spleen germinal center number J:82813
Ikzf1tm1Kge/Ikzf1+
involves: 129S4/SvJae * BALB/c 		abnormal lymph node cortex morphology J:29355
abnormal lymph node medulla morphology J:29355
abnormal T cell differentiation J:29355
abnormal thymocyte activation J:29355
abnormal thymus lobule morphology J:29355
abnormal thymus medulla morphology J:29355
decreased spleen red pulp amount J:29355
enlarged cervical lymph nodes J:29355
enlarged mesenteric lymph nodes J:29355
enlarged thymus J:29355
increased leukemia incidence J:29355
increased spleen white pulp amount J:29355
increased T cell proliferation J:29355
lymph node hyperplasia J:29355
premature death J:29355
spleen hyperplasia J:29355
thymus cortex hypoplasia J:29355
Ikzf1tm1Kge/Ikzf1+
involves: 129S4/SvJae * C57BL/6 		abnormal lymph node cortex morphology J:29355
abnormal lymph node medulla morphology J:29355
abnormal T cell differentiation J:29355
abnormal thymocyte activation J:29355
abnormal thymus lobule morphology J:29355
abnormal thymus medulla morphology J:29355
decreased spleen red pulp amount J:29355
enlarged cervical lymph nodes J:29355
enlarged mesenteric lymph nodes J:29355
enlarged thymus J:29355
increased leukemia incidence J:29355
increased spleen white pulp amount J:29355
increased T cell proliferation J:29355
lymph node hyperplasia J:29355
premature death J:29355
spleen hyperplasia J:29355
thymus cortex hypoplasia J:29355
Ikzf1tm1Kge/Ikzf1tm1Kge
involves: 129S4/SvJae * BALB/c 		abnormal common myeloid progenitor cell morphology J:20671
abnormal definitive hematopoiesis J:20671
abnormal eosinophil morphology J:20671
abnormal erythroid progenitor cell morphology J:20671
abnormal gut flora balance J:20671
abnormal immune system organ morphology J:20671
abnormal NK cell morphology J:20671
abnormal spleen morphology J:20671
abnormal thymus cortex morphology J:20671
abnormal thymus morphology J:20671
absent axillary lymph nodes J:20671
absent B cells J:20671
absent cervical lymph nodes J:20671
absent inguinal lymph nodes J:20671
absent mesenteric lymph nodes J:20671
absent Peyer's patches J:20671
absent pre-B cells J:20671
arrested T cell differentiation J:20671
decreased body size J:20671
decreased bone marrow cell number J:20671
decreased gamma-delta intraepithelial T cell number J:20671
enlarged spleen J:20671
extramedullary hematopoiesis J:20671
increased basophil cell number J:20671
increased nucleated erythrocyte cell number J:20671
increased susceptibility to bacterial infection J:20671
intermingled spleen red and white pulp J:20671
lung inflammation J:20671
multifocal hepatic necrosis J:20671
postnatal lethality, incomplete penetrance J:20671
thymus hypoplasia J:20671
Ikzf1tm1Kge/Ikzf1tm1Kge
involves: 129S4/SvJae * C57BL/6 		abnormal common myeloid progenitor cell morphology J:20671
abnormal definitive hematopoiesis J:20671
abnormal eosinophil morphology J:20671
abnormal erythroid progenitor cell morphology J:20671
abnormal gut flora balance J:20671
abnormal immune system organ morphology J:20671
abnormal NK cell morphology J:20671
abnormal spleen morphology J:20671
abnormal thymus cortex morphology J:20671
abnormal thymus morphology J:20671
absent axillary lymph nodes J:20671
absent B cells J:20671
absent cervical lymph nodes J:20671
absent inguinal lymph nodes J:20671
absent mesenteric lymph nodes J:20671
absent Peyer's patches J:20671
absent pre-B cells J:20671
arrested T cell differentiation J:20671
decreased body size J:20671
decreased bone marrow cell number J:20671
decreased gamma-delta intraepithelial T cell number J:20671
enlarged spleen J:20671
extramedullary hematopoiesis J:20671
increased basophil cell number J:20671
increased nucleated erythrocyte cell number J:20671
increased susceptibility to bacterial infection J:20671
intermingled spleen red and white pulp J:20671
lung inflammation J:20671
multifocal hepatic necrosis J:20671
postnatal lethality, incomplete penetrance J:20671
thymus hypoplasia J:20671
Ikzf1tm2.1Smale/Ikzf1tm2.1Smale
B6.Cg-Ikzf1tm2.1Smale 		abnormal definitive hematopoiesis J:208211
abnormal lymphopoiesis J:208211
abnormal peripheral lymph node morphology J:208211
abnormal T cell differentiation J:208211
absent inguinal lymph nodes J:208211
absent NK cells J:208211
absent Peyer's patches J:208211
decreased B cell number J:208211
decreased body size J:208211
decreased DN2 thymocyte number J:208211
decreased DN3 thymocyte number J:208211
decreased double-negative T cell number J:208211
decreased double-positive T cell number J:208211
decreased immature B cell number J:208211
decreased mature B cell number J:208211
decreased plasmacytoid dendritic cell number J:208211
decreased pre-pro B cell number J:208211
normal immune system phenotype J:208211
increased gamma-delta T cell number J:208211
increased lymphoma incidence J:208211
increased pre-B cell number J:208211
premature death J:208211
thymus cortex hypoplasia J:208211
thymus hypoplasia J:208211
Ikzf1tm2Kge/Ikzf1tm2.1Smale
involves: 129S4/SvJae * C57BL/6 		lethality, complete penetrance J:208211
Ikzf1tm2Kge/Ikzf1tm2Kge
involves: 129S4/SvJae 		abnormal dendritic cell number J:37317
abnormal erythropoiesis J:37317
abnormal splenic cell ratio J:37317
abnormal T cell differentiation J:37317, J:208211
abnormal thymus development J:37317
absent axillary lymph nodes J:37317
absent B cells J:37317, J:208211
absent B-1a cells J:37317
absent cervical lymph nodes J:37317
absent inguinal lymph nodes J:37317
absent mesenteric lymph nodes J:37317
absent NK cells J:37317, J:208211
absent Peyer's patches J:37317
absent pre-B cells J:37317
absent pro-B cells J:37317
decreased double-positive T cell number J:37317
decreased gamma-delta intraepithelial T cell number J:37317
decreased granulocyte number J:37317
decreased mature gamma-delta T cell number J:37317
decreased plasmacytoid dendritic cell number J:208211
decreased splenocyte number J:37317
increased T cell proliferation J:37317
thymus hypoplasia J:37317
Ikzf1tm3.1Mbu/Ikzf1tm3.1Mbu
Il7rtm1.1(icre)Hrr/Il7r+
involves: 129P2/OlaHsd * C57BL/6 * SJL 		increased T cell derived lymphoma incidence J:209928
Ikzf1tm3Kge/Ikzf1tm3Kge
Tg(CD2-icre)4Kio/?
involves: C57BL/10 * CBA/Ca 		abnormal B cell physiology J:209927
impaired B cell migration J:209927
increased T cell derived lymphoma incidence J:209927
Ikzf1tm3Kge/Ikzf1tm3Kge
Tg(CD19-cre/ERT2)1Cgn/?
Not Specified 		abnormal B cell apoptosis J:209927
absent pre-B cells J:209927
decreased pre-B cell number J:209927
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory